Human myeloma cell line (KHM-4) established from a patient with multiple myeloma associated with hyperammonemia
- PMID: 1611184
- DOI: 10.2169/internalmedicine.31.339
Human myeloma cell line (KHM-4) established from a patient with multiple myeloma associated with hyperammonemia
Abstract
A cell line of plasma cells with high ammonia (NH3) production (KHM-4) was established from a patient with multiple myeloma complicated by hyperammonemia and abnormal serum concentrations of amino acids. Surface marker studies of KHM-4 cells showed that the cells were positive for cytoplasmic immunoglobulins (IgA kappa), HLA-DR, and T 10. Secretion of ammonia by the KHM-4 cells was detected by the addition of L-glutamine and L-arginine into the culture medium of amino acid-free RPMI 1640. In the presence of L-glutamine, KHM-4 cells secreted a greater amount of ammonia than the T cell line, CEM. However, production of ammonia by L-arginine was not observed in other cell lines. These observations provide evidence for the existence of a peculiar amino acid metabolism in the myeloma cells causing hyperammonemia and serum amino acid disturbance.
Similar articles
-
Establishment of a CD45-positive immature plasma cell line from an aggressive multiple myeloma with high serum lactate dehydrogenase.Leukemia. 1994 Oct;8(10):1768-73. Leukemia. 1994. PMID: 7934174
-
Establishment and characterization of an amylase-producing human myeloma cell line.Blood. 1988 Sep;72(3):978-82. Blood. 1988. PMID: 2458153
-
Establishment and characterization of a CD95 (Fas/Apo-1)-negative myeloma cell line.Acta Haematol. 1999;101(3):113-8. doi: 10.1159/000040935. Acta Haematol. 1999. PMID: 10352328
-
[Clinicopathological study of multiple myeloma associated with hyperammonemia].Rinsho Ketsueki. 1998 Jan;39(1):27-33. Rinsho Ketsueki. 1998. PMID: 9492550 Review. Japanese.
-
Ammonia toxicity to the brain and creatine.Mol Genet Metab. 2004 Apr;81 Suppl 1:S52-7. doi: 10.1016/j.ymgme.2003.10.014. Mol Genet Metab. 2004. PMID: 15050974 Review.
Cited by
-
Establishment of induced pluripotent stem cells from normal B cells and inducing AID expression in their differentiation into hematopoietic progenitor cells.Sci Rep. 2017 May 10;7(1):1659. doi: 10.1038/s41598-017-01627-1. Sci Rep. 2017. PMID: 28490810 Free PMC article.
-
Establishment of a monoclonal antibody to human myeloma cell: relation to chemotherapy and extramedullar infiltration.Med Oncol. 1998 Dec;15(4):248-54. doi: 10.1007/BF02787208. Med Oncol. 1998. PMID: 9951688
-
Chromosomal translocation t(11;14) and p53 deletion induced by the CRISPR/Cas9 system in normal B cell-derived iPS cells.Sci Rep. 2021 Mar 4;11(1):5216. doi: 10.1038/s41598-021-84628-5. Sci Rep. 2021. PMID: 33664418 Free PMC article.
-
High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations.Cancers (Basel). 2022 Jan 26;14(3):610. doi: 10.3390/cancers14030610. Cancers (Basel). 2022. PMID: 35158878 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous